Skip to main content


Study Title Study Sponsor Status Study Drug Trial Phase Study Protocol Number Site
A single arm, multicentre observational study to evaluate effectiveness of pegcetacoplan under real world conditions in patients with paroxysmal nocturnal hemoglobinuria (PNH) COMPLETE Sobi - Swedish Orphan Biovitrum AG Ongoing pegcetacoplan (ASPAVELI) 4 Sobi.PEGCE King Faisal Specialist Hospital and Research Center (Jeddah)
The Effect of Black Seeds (Nigella Sativa) on Prediabetic Overweight and Obese Adolescents Imam Abdulrhman bin Faisal university Ongoing Nigella sativa seeds 3 2230500005 Family and Community Medicine Center (Dammam)
A Randomized, Double Blinded, Comparative Observational Interventional Study to Assess The Safety And Immunogenicity Of Hepatitis B Vaccine In Newborns / Adolescents And Adults Six Months Post Vaccination Arab Company for Pharmaceutical products Ongoing EUVAX B VACCINE 4 HBV-001 King Fahad Medical City (Riyadh)
Impact of using Zinc Oxide versus Moist Exposed Wound Ointment (MEBO) in treatment of second stage pressure ulcer: A randomized control clinical trial King Abdullah Medical City (Makkah) Ongoing MEBO and Zinc oxide topical 3 Version 5 King Abdullah Medical City (Makkah)
A Proof of Concept, Phase IIa, Open Label Study to Evaluate the Safety and Efficacy of Subcutaneous Implants of Afamelanotide in Patients with Xeroderma Pigmentosum (XP) CLINUVEL EUROPE LIMITED Ongoing Afamelanotide 2a CUV156 King Faisal Specialist Hospital and Research Center (Riyadh)
A randomized, double-blind, double-dummy, parallel-group study, comparing the efficacy and safety of remibrutinib versus teriflunomide in participants with relapsing multiple sclerosis, followed by extended treatment with open-label remibrutinib Novartis Ongoing remibrutinib 3 CLOU064C123 King Faisal Specialist Hospital and Research Center (Jeddah) - King Abdulaziz Medical City NG (Jeddah) - King Abdulaziz Medical City NG (Riyadh)
An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900, an Oral Plasma Kallikrein Inhibitor, for On-demand Treatment of Angioedema Attacks in Adolescent and Adult Patients with Hereditary Angioedema Type I or II KalVista Pharmaceuticals Ltd Ongoing Sebetralstat 3 KVD900-302 King Faisal Specialist Hospital and Research Center (Riyadh)
A prospective observational international study of cabozantinib tablets in combination with nivolumab as first-line treatment of advanced renal cell carcinoma in adults Ipsen Pharma Ongoing Cabozantinib 4 CLIN-60000 King Abdulaziz Medical City NG (Riyadh)
A Phase 3, Randomized, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Guselkumab in Participants with Fistulizing, Perianal Crohn’s Disease Janssen Research & Development LLC Ongoing Guselkumab 3 CNTO1959CRD3005 King Faisal Specialist Hospital and Research Center (Riyadh), King Fahad Specialist Hospital (Dammam), King Saud Medical City (Riyadh), King Abdulaziz Medical City NG (Jeddah)
A Randomized, Double-blind, Multicenter Study to Determine the Effect of Triheptanoin Compared with Even-chain, Medium-chain Triglycerides (MCT) on Major Clinical Events (MCEs) in Pediatric Patients with Long-chain Fatty Acid Oxidation Disorders (LC-FAOD) Ultragenyx Pharmaceutical Inc Ongoing UX007/triheptanoin, Medium-chain Triglycerides (MCT),Dextrose. Monosaccharide. Blood Glucose-Elevating Agents. 3 UX007-CL30 King Faisal Specialist Hospital and Research Center (Riyadh)
View 1 - 10 From 692